Novartis' expenses by type 2018-2019

This statistic shows the expenses of Swiss-based pharmaceutical company Novartis in 2018 and 2019, by major type. Novartis AG is one of the world's largest pharma companies. In 2019, Novartis spent approximately 14.4 billion U.S. dollars on selling, general and administration (SG&A).

Novartis AG's expenses in 2018 and 2019, by type (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2020

Region

Worldwide

Survey time period

2018 and 2019

Supplementary notes

* Costs of sold goods are not included.
** During 2019, the eye care division Alcon spun off and became a separate company. Thus, Alcon's expenses are not included.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Novartis"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.